Replies to post #3925 on Phio Pharmaceuticals Corp (PHIO)

[BioPharma]

I agree with you. For scar trials, cohort 1 and 2, the three doses showed improvement 54%, and six doses showed 68% improvement. So for cohort 3 and 4 treated with 9 doses and longer period, do you think the results will be better?

And for Samcyprone with improved composition, and longer treatment, I think the results will be better, Pavco said the first two patients showed very good result with this new improved protocol.